CHELMSFORD, Mass., February 6, 2012 - Brooks Automation, Inc. (Nasdaq:BRKS), a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets, today announced the presence of its Brooks Life Science Systems division at the inaugural Society for Laboratory Automation and Screening (SLAS) Conference in San Diego, CA.
Brooks Life Science Systems is the leading worldwide provider of automation solutions for compound and biological sample storage and management with an installed global base of more than 180 systems, including installations at the world’s top 20 pharmaceutical and biotechnology companies.
Dr. Steve Schwartz, President and CEO of Brooks Automation, said, “Brooks entered into the Life Sciences market in 2011 and now, with the acquisitions of industry specialists RTS Life Science, REMP®, and Nexus Biosystems, we have chosen the prestigious SLAS Conference to rollout our full offering to the Life Science industry. In Brooks Life Science Systems we combine the expertise and experience of these three leading sample management companies, alongside the extensive R&D capabilities and global service reach of Brooks Automation.”
“This is an exciting time as we continue to build on our long term commitment to supporting life science research,” commented Clint Haris, Senior Vice President, General Manager, Brooks Life Science Systems. “As pioneers in automation, we are wholly committed to focusing our R&D activities on pushing the boundaries of automated sample management and storage. Our mission is to continuously provide innovative solutions that improve sample integrity and data security during automated sample storage and management, as well as advancing the operational performance and efficiencies of our systems.”
At the conference, Booth #918, Brooks Life Science Systems will be showcasing the latest solutions in automated storage and its portfolio of products designed to meet the most demanding needs in sample management including its most recent product acquisitions, Celigo® and Plate Auditor™. Celigo is a high throughput, microplate-based, imaging cell cytometer and analysis system. Celigo provides high productivity automated solutions for the analysis, handling and testing of biological and compound samples prior to and following their storage in automated sample management systems. The Brooks Plate Auditor will help Compound Sample Managers analyze the quality of their compounds following storage and prior to the sample’s entry into the high throughput screening phase of the drug discovery process. Brooks will be hosting a tutorial: “Automated Biorepository Sample Workflow”, at the SLAS Conference on Tuesday, February 7th, 8:00 a.m. – 8:50 a.m., Room 8 on the upper level of the San Diego Convention Center.
About Brooks Life Science Systems
Brooks Life Science Systems is a leading worldwide provider of automation and related solutions for compound and biological sample storage, management and analysis. The Company combines the specialist expertise of industry-renowned brands, REMP®, Nexus, and RTS, together with the extensive R&D and global service capabilities of Brooks Automation.
Brooks Life Science Systems partners with its customers, working as a trusted advisor from specification, to system installation and ongoing service and customer support. From standardized bench top systems to custom installations, Brooks has the largest installed base of automated storage systems and support network in the Life Sciences industry, with more than 180 systems across the globe including the top 20 pharmaceutical and biotechnology companies.
As pioneers in automated storage, Brooks Life Science Systems continually focuses its R&D activities on providing innovative solutions to maintaining sample integrity and security during sample storage, handling, analyzing and processing applications. Solutions provided by Brooks are transforming the productivity and streamlining the workflow of scientists across a broad range of life science applications, including drug discovery and biobanking.
Brooks Life Science Systems is a division of Brooks Automation, Inc (NASDAQ: BRKS), a public listed company with headquarters in North America and operations throughout North America, Europe and Asia. For more information, please visit www.brooks.com
About Brooks Automation, Inc.
Brooks is a leading worldwide provider of automation, vacuum and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. The Company’s technologies, engineering competencies and global service capabilities provide customers speed to market, and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market and through product development initiatives and strategic business acquisitions; the Company has expanded its reach to meet the needs of customers in the life sciences industry, analytical & research markets and clean energy solutions. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe and Asia. For more information, please visit www.brooks.com
"Safe Harbor Statement" under Section 21E of the Securities Exchange Act of 1934
Some statements in this release are forward-looking statements made under Section 21E of the Securities Exchange Act of 1934. These statements are neither promises nor guarantees but involve risks and uncertainties, both known and unknown, that could cause Brooks' financial and business results to differ materially from our expectations. They are based on the facts known to management at the time they are made. These forward-looking statements include statements regarding future adoption of new technologies and our ability to develop further our business. Factors that could cause results to differ from our expectations and other risks that we have identified are described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K, current reports on Form 8-K and our quarterly reports on Form 10-Q. As a result we can provide no assurance that our future results will not be materially different from those projected. Brooks expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based. Brooks undertakes no obligation to update the information contained in this press release.
MEDIA CONTACT:
Lynne Trowbridge, Dimithri Wignarajah
College Hill Life Sciences
Tel: +44 20 7866 7858
Email: [email protected]